The Journal of Medical Investigation
Online ISSN : 1349-6867
Print ISSN : 1343-1420
ISSN-L : 1343-1420
Immune-nutritional indexes for predicting the response to nivolumab immunotherapy in gastric cancer
Yuma Wada, Masaaki Nishi, Chie Takasu, Takuya Tokunaga, Hideya Kashihara, Toshiaki Yoshimoto, Mitsuo Shimada
Author information
Keywords: NLR, LCR, PNI, osteopenia, sarcopenia
JOURNAL FREE ACCESS

2026 Volume 73 Issue 3.4 Pages 326-333

Details
Abstract

Background:Immune checkpoint inhibitors reportedly improve survival outcomes in patients with gastric cancer (GC). However, most patients develop disease progression, for which treatment options are limited. We examined biomarkers for identification of patients with good response for promising treatment like immune checkpoint inhibitors. Methods:We analyzed 40 patients with clinical unresectable or recurrent GC who received nivolumab immunotherapy and divided them into a responder group (n=7) and non-responder group (n=33) based on the RECIST criteria. We prioritized the following biomarkers:nutritional markers (prognostic nutritional index [PNI], lymphocyte-to-plasma C-reactive protein ratio [LCR], and neutrophil–lymphocyte ratio [NLR]), sarcopenia, and osteopenia. Results:Our model predicted the response to nivolumab with excellent accuracy in immune-nutritional markers (LCR:area under the curve [AUC]=0.74, NLR:AUC=0.75, PNI:AUC=0.60), osteopenia (AUC=0.83), and sarcopenia (AUC=0.73). Moreover, the predictive accuracy of the risk-assessment model was superior to that of each parameter (AUC=0.93). Univariate Cox proportional hazard regression analysis revealed that our model was an independent predictor of survival outcomes (hazard ratio=3.22, 95% confidence interval=1.62–6.42, P<0.01). Conclusions:Measurement of nutritional markers, osteopenia, and sarcopenia allowed prediction of a response to nivolumab immunotherapy. Our novel risk-assessment model for predicting the response to nivolumab has potential for clinical translation. J. Med. Invest. 73 : 326-333, August, 2026

Content from these authors
© by The University of Tokushima Faculty of Medicine
Previous article Next article
feedback
Top